Potential nondopaminergic drugs for Parkinson's disease.

MA Silverdale, SH Fox, AR Crossman, JM Brotchie

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)273-291
    Number of pages19
    JournalAdvances in Neurology
    Volume91
    Publication statusPublished - 2003

    Keywords

    • Animals
    • adverse effects: Antiparkinson Agents
    • metabolism: Basal Ganglia
    • Drug Therapy, Combination
    • Human
    • adverse effects: Levodopa
    • Models, Neurological
    • metabolism: Neural Pathways
    • agonists: Neurotransmitters
    • drug therapy: Parkinson Disease
    • agonists: Receptors, Neurotransmitter
    • metabolism: Substantia Nigra
    • Support, Non-U.S. Gov't

    Cite this